Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Drug Alcohol Depend. 2008 Feb 1;94(1-3):172–182. doi: 10.1016/j.drugalcdep.2007.11.012

Table 1.

Comparison of Sample Characteristics by Total Sample and Intervention Condition

SOC
n = 230
MI
n = 226
SBCM
n = 222
Total Sample
n=678
Age 33.6 32.9 33.8 33.4
Gender (%)
    Male 63.0 (145) 63.3 (143) 63.5 (141) 63.3 (429)
    Female 37.0 (85) 36.7 (83) 36.5 (81) 36.7 (249)
Ethnicity (%)
    White 51.3 (118) 52.7 (119) 49.1 (109) 51.0 (346)
    African American 47.4 (109) 46.9 (106) 50.0 (111) 48.1 (326)
    Other 1.3 (3) 0.4 (1) 0.9 (2) 0.9 (6)
Involved in CJ system (%)
    Yes 50.0 (115) 52.2 (118) 48.6 (108) 50.3 (341)
Homeless (%)
    Yes 18.7 (43) 16.8 (38) 25.2 (56) 20.2 (137)
Prior Treatment (%)
    Yes 68.7 (158) 69.5 (157) 72.14 (160) 70.1 (475)
Education Level 11.4 11.2 11.0 11.2
Drug of Choice (%)
    Alcohol 12.7 (29) 13.8 (31) 8.2 (18) 11.6 (78)
    Heroin 19.3 (44) 22.7 (51) 24.1 (53) 22.0 (148)
    Cocaine/Crack 47.4 (108) 39.6 (89) 50.0 (110) 45.6 (307)
    Cannabis 14.0 (32) 17.8 (40) 12.7 (28) 14.9 (100)
    Other 6.6 (15) 6.2 (14) 5.0 (11) 5.9 (40)
Barriers to Treatment
    Absence Problem* 10.67 11.52 10.13 10.77
    Negative Social Support 8.11 7.98 8.12 8.07
    Treatment Fear 7.47 7.18 7.01 7.22
    Privacy Concerns 8.18 7.77 8.16 8.02
    Committed Lifestyle 4.97 4.88 5.05 4.96
    Time Conflict 3.93 3.85 3.74 3.87
    Poor Treatment Availability 5.40 5.32 5.28 5.33
    Admission Difficulties 5.25 4.98 5.06 5.10
    Financial Problem 7.59 7.75 7.48 7.61
Pre-Treatment Readiness
    Problem Recognition 39.28 37.64 39.50 38.81
    Desire for Change 13.71 13.61 13.90 13.74
    Treatment Readiness 17.53 17.37 17.76 17.55
    Treatment Reluctance 6.45 6.50 6.17 6.37
ASI Composites
    Psychiatric * .278 .226 .285 .263
    Alcohol .153 .124 .160 .146
    Drug .195 .201 .205 .200
    Medical .199 .211 .251 .220
    Family/Social Support .195 .183 .201 .193
    Legal .202 .223 .200 .209
    Employment .772 .771 .792 .778
Modality Referred to (%)
    Residential 33.5 29.2 32.9 31.9 (216)
    Outpatient 50.0 50.0 49.1 49.7 (337)
    Methadone 16.5 20.8 18.0 18.4 (125)
*

p < .05